PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
Value-based care and contracting is receiving substantial attention across the health care landscape as a tool for improving patient care and managing costs, and pharmaceuticals…
Who would have imagined one of the hottest online trends would be pharmaceuticals for weight loss? Social media and commercials are flooded with advertisements for…
(DALLAS, TX) – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering visibility…
The pharmacy benefit management landscape is complex and ever-changing. With many new high-cost trending therapies currently available in addition to those on the horizon, managing…
Key Metrics: 7% of PBM claims processed incorrectly $600K of reimbursement dollars due to client Background When a large government organization discovered that their average…
On March 15th the Centers for Medicare and Medicaid Services (CMS) released initial guidance on the Medicare Drug Price Negotiation Program (or “Negotiation Program”),…
Key Metrics: $5B amount saved by PSG’s RFP procurement clients in just one year. Background When planning their annual budget, a national retail employer decided…
Today is a milestone in the world of biosimilars, as the first Humira® biosimilar Amjevita™ (adalimumab-atto), manufactured by Amgen, has launched in the U.S. Will it have…
Revolutionary Drug Management Reporting Tool Offers Powerful User Insights Dallas, TX (January 23, 2023) – Artemetrx®, the industry’s most preeminent platform for integrated drug cost management,…
